Anticoagulants, antiplatelet agents, fibrinolytics, and thrombolytics have no therapeutic value and may be harmful. Other therapies that have been used but were found to be ineffective include surgical decompression, low molecular weight dextran, hemodilution, and carbon dioxide inhalation. Some patients will have decreased macular edema as long as they remain on the medication. Photocoagulation is currently the treatment of choice. However, considerable debate continues regarding whom the treatment may benefit.
Ophthalmologic consultation is mandatory.
Treatment of RVO is outside the scope of emergency medicine. The goal of therapy is to reduce macular edema. In addition, these agents modify the body's immune response to diverse stimuli. By reversing increased capillary permeability and suppressing PMN activity, may decrease inflammation. An enzyme found in many tissues of the body, including the eye, which catalyzes a reversible reaction that involves the hydration of carbon dioxide and the dehydration of carbonic acid.